Stockholm (HedgeNordic) – Investing directly into unlisted privately-held businesses can sometimes be more lucrative than investing in publicly-traded businesses. Swedish asset manager Norron Asset Management, for instance, has seen its first unlisted holding – Norwegian clinical-stage biopharmaceutical company Vaccibody – surge in value by approximately 2,000 percent since investing in the company in December 2016. … Continue reading Norron’s Multibagger